Beyond weight loss:
Obesity trial design for real-world patient and payer impact

As obesity therapies reshape the treatment landscape, sponsors face increasing pressure to demonstrate value beyond weight loss alone. Regulators, payers, providers and patients increasingly expect evidence of long-term outcomes, quality of life, adherence and economic impact.

Success in obesity drug development depends on generating evidence that balances scientific rigor with real-world relevance. This requires thoughtful endpoint selection, patient-centric trial strategies and an integrated approach to evidence generation.

Watch our experts explore innovative approaches to designing obesity clinical trials, with practical strategies for creating a stronger evidence package that resonates with regulators, payers and patients alike.

Watch this webinar and learn:

• How obesity trial endpoints are evolving beyond traditional measures of weight reduction
• Strategies for incorporating patient-centric approaches and capturing what matters most to patients
• Considerations for generating payer-relevant evidence earlier in development
• Opportunities to leverage real-world data and patient insights to strengthen development programs
• Best practices for designing studies that demonstrate both clinical and economic value